These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 21780551)
61. Diseases of the digestive tract: is prevention possible and feasible? Malagelada JR Dig Dis; 2011; 29(2):255-63. PubMed ID: 21734393 [TBL] [Abstract][Full Text] [Related]
63. Effect of the trehalose levels on the screening of yeast as probiotic by in vivo and in vitro assays. Martins FS; Miranda IC; Rosa CA; Nicoli JR; Neves MJ Braz J Microbiol; 2008 Jan; 39(1):50-5. PubMed ID: 24031177 [TBL] [Abstract][Full Text] [Related]
64. [Gastroenterology in Germany today: development, achievements, challenges]. Layer P Z Gastroenterol; 2013 Jun; 51(6):541-3. PubMed ID: 23740352 [No Abstract] [Full Text] [Related]
65. Biotherapeutic and nutraceutical agents: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. Yamashiro Y; Castaneda C; Davidson G; Gibson G; Penna FJ; Mack D; Splawski J; J Pediatr Gastroenterol Nutr; 2004 Jun; 39 Suppl 2():S596-600. PubMed ID: 15184758 [No Abstract] [Full Text] [Related]
66. [The modern condition of pediatric gastroenterology in America]. Riedel BD Eksp Klin Gastroenterol; 2013; (1):79-81. PubMed ID: 23951905 [No Abstract] [Full Text] [Related]
68. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Kelesidis T; Pothoulakis C Therap Adv Gastroenterol; 2012 Mar; 5(2):111-25. PubMed ID: 22423260 [TBL] [Abstract][Full Text] [Related]
69. The small gastroenterology practice: how to survive in a changing world. Perspectives of a practicing clinician. Fogel R Clin Gastroenterol Hepatol; 2015 Mar; 13(3):419-21. PubMed ID: 25500132 [No Abstract] [Full Text] [Related]
70. Regenerative medicine and the gut. Peterson J; Pasricha PJ Gastroenterology; 2011 Oct; 141(4):1162-6, 1166.e1-2. PubMed ID: 21864477 [No Abstract] [Full Text] [Related]
71. Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic Science. Petrof EO Antiinflamm Antiallergy Agents Med Chem; 2009 Sep; 8(3):260-269. PubMed ID: 20890386 [TBL] [Abstract][Full Text] [Related]
72. Examining the evidence for the use of probiotics in clinical practice. Hickson M Nurs Stand; 2013 Mar 20-26; 27(29):35-41. PubMed ID: 23634499 [TBL] [Abstract][Full Text] [Related]
79. Use of probiotics in clinical practice with special reference to diarrheal diseases: A position statement of the Malaysian Society of Gastroenterology and Hepatology. Lee YY; Leow AH; Chai PF; Raja Ali RA; Lee WS; Goh KL JGH Open; 2021 Jan; 5(1):11-19. PubMed ID: 33490608 [TBL] [Abstract][Full Text] [Related]
80. Therapeutic correction of bacterial dysbiosis discovered by molecular techniques. Sartor RB Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16413-4. PubMed ID: 18948599 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]